Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Wireless subscriber managing storage of HARQ packets
Peer-to-peer method of deploying and managing executable code and associated plug-ins
Matching engine for comparing data feeds with user profile criteria
Tree drain grate
Method for production of fermentable sugars from biomass
Systems and methods for economic retirement analysis
Performing a cyclic redundancy checksum operation responsive to a user-level instruction
  Randomly Featured Patents
Methods to produce 3,3,3-trifluoropropene
Condensation polymers having covalently bound carbon nanotubes
Toy rocking horse
Projected scanning laser device and method for locating small objects
Process for coating paper, paperboard, and molded fiber with a water-dispersible polyester polymer
Power correction module for power amplifiers
Seat belt buckle presenter and method of use therefor
Drive means for flexible eversion tube system
Welding wire verification control system
Sulphated K5 antigen and sulphated K5 antigen fragments